2022-RA-276-ESGO Value of surgical cytoreduction for subsequent ovarian cancer relapse in patients previously treated with chemotherapy alone at 1st-relapse: a subanalysis of the DESKTOP III/ENGOT-ov20 trial

Authors :: Christina Fotopoulou
Jalid Sehouli
Ignace Vergote
Alexander Reuss
Marianne Leheurteur
Felix Hilpert
Aude-Marie Savoye
Stefano Greggi
Johanna Vernersson
Benoît Resch
Michel Gatineau
Jean Levêque
Rongyu Zang
Pernille T Jensen
Jae W Kim
Domingo Santiago
Francesco Raspagliesi
Ulla Peen
Andreas du Bois
Philipp Harter
Source :: Ovarian cancer.
Publication Year :: 2022
Publisher :: BMJ Publishing Group Ltd, 2022.

Full Text Access

Tools